Constitutive/hypoxic degradation of HIF-α proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein

被引:62
|
作者
Kong, Xianguo
Alvarez-Castelao, Beatriz
Lin, Zhao
Castano, Jose G.
Caro, Jaime
机构
[1] Thomas Jefferson Univ, Cardeza Fdn, Philadelphia, PA 19107 USA
[2] UAM, Fac Med, CSIC, Dept Bioquim, Madrid, Spain
[3] UAM, Inst Invest Biomed Alberto Sols, CSIC, Fac Med, Madrid, Spain
关键词
D O I
10.1074/jbc.M700704200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcriptional activator complex HIF-1 plays a key role in the long term adaptation of cells and tissues to their hypoxic microenvironment by stimulating the expression of genes involved in angiogenesis and glycolysis. The expression of the HIF-1 complex is regulated by the levels of its HIF-alpha subunits that are degraded under normoxic conditions by the ubiquitin-proteasome system. Whereas this pathway of HIF-alpha protein degradation has been well characterized, little is known of their turnover during prolonged hypoxic conditions. Herein, we describe a pathway by which HIF-1 alpha and HIF-2 alpha proteins are constitutively degraded during hypoxia by the proteasome system, although without requirement of prior ubiquitylation. The constitutive/hypoxic degradation of HIF-alpha proteins is independent of the presence of VHL, binding to DNA, or the formation of a transcriptionally active HIF-1 complex. These results are further strengthened by the demonstration that HIF-alpha proteins are directly degraded in a reconstituted in vitro assay by the proteasome. Finally, we demonstrate that the persistent down-regulation of HIF-1 alpha during prolonged hypoxia is mainly caused by a decreased production of the protein without change in its degradation rate. This constitutive, ubiquitin-independent proteasomal degradation pathway of HIF-alpha proteins has to be taken into account in understanding the biology as well as in the development of therapeutic interventions of highly hypoxic tumors.
引用
收藏
页码:15498 / 15505
页数:8
相关论文
共 50 条
  • [1] Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
    Jaakkola, P
    Mole, DR
    Tian, YM
    Wilson, MI
    Gielbert, J
    Gaskell, SJ
    von Kriegsheim, A
    Hebestreit, HF
    Mukherji, M
    Schofield, CJ
    Maxwell, PH
    Pugh, CW
    Ratcliffe, PJ
    SCIENCE, 2001, 292 (5516) : 468 - 472
  • [2] The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing
    Kaelin, WG
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (01) : 627 - 638
  • [3] The von Hippel-Lindau protein: insights into hypoxic signaling and cancer
    Kaelin, W., Jr.
    EJC SUPPLEMENTS, 2008, 6 (09): : 61 - 61
  • [4] p53 stabilization and transactivation by a von Hippel-Lindau protein
    Roe, Jae-Seok
    Kim, Hyungsoo
    Lee, Soon-Min
    Kim, Sung-Tae
    Cho, Eun-Jung
    Youn, Hong-Duk
    MOLECULAR CELL, 2006, 22 (03) : 395 - 405
  • [5] The von Hippel-Lindau Tumor Suppressor Protein Promotes c-Cbl-Independent Poly-Ubiquitylation and Degradation of the Activated EGFR
    Zhou, Liang
    Yang, Haifeng
    PLOS ONE, 2011, 6 (09):
  • [6] Genotype and p'henotype correlation in von Hippel-Lindau disease based on alteration of the HIF-α binding site in VHL protein
    Liu, Sheng-Jie
    Wang, Jiang-Yi
    Peng, Shuang-He
    Li, Teng
    Ning, Xiang-Hui
    Hong, Bao-An
    Liu, Jia-Yuan
    Wu, Peng-Jie
    Zhou, Bo-Wen
    Zhou, Jing-Cheng
    Qi, Nie-Nie
    Peng, Xiang
    Zhang, Jiu-Feng
    Ma, Kai-Fang
    Cai, Lin
    Gong, Kan
    GENETICS IN MEDICINE, 2018, 20 (10) : 1266 - 1273
  • [7] Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
    Kondo, K
    Klco, J
    Nakamura, E
    Lechpammer, M
    Kaelin, WG
    CANCER CELL, 2002, 1 (03) : 237 - 246
  • [8] Targeted protein degradation bypassing cereblon and von Hippel-Lindau
    Lu, Wenchao
    INNOVATION, 2023, 4 (03):
  • [9] Functional interaction between gene transactivation, ubiquitylation and proteasome- mediated protein degradation
    Zhu, Q
    Yao, J
    Wani, MA
    Wani, G
    Wang, Q
    Wani, AA
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 327 - 327
  • [10] The Von Hippel-Lindau Protein Suppresses Androgen Receptor Activity
    Wang, Jing
    Zhang, Wei
    Ji, Wei
    Liu, Xing
    Ouyang, Gang
    Xiao, Wuhan
    MOLECULAR ENDOCRINOLOGY, 2014, 28 (02) : 239 - 248